{"id":69815,"date":"2013-01-12T12:47:17","date_gmt":"2013-01-12T12:47:17","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/the-most-interesting-thing-at-jpmorgans-health-care-conference.php"},"modified":"2013-01-12T12:47:17","modified_gmt":"2013-01-12T12:47:17","slug":"the-most-interesting-thing-at-jpmorgans-health-care-conference","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/health-care\/the-most-interesting-thing-at-jpmorgans-health-care-conference.php","title":{"rendered":"The Most Interesting Thing at JPMorgan&#39;s Health Care Conference"},"content":{"rendered":"<p><p>    By     Brian Orelli | More Articles    January 11, 2013 |  <\/p>\n<p>      JPMorgan's health care conference is a treasure-trove of      information about health care companies. From basic      information to fourth quarter sales, even a few deals are      signed, sealed, and announced at JPMorgan.    <\/p>\n<p>      But the most interesting -- both entertaining and educational      -- part of the meeting happened virtually when attendees and      remote observers of the conference piled onto a Twitter      hashtag,       #jpmpickuplines, scientifically mocking what an attendee      might say to pick up someone at the hotel bar.    <\/p>\n<p>      \"Best set of data points I've seen all year,\"       tweeted San Francisco Business Times reporter      Ron Leuty who started the meme.    <\/p>\n<p>      The top one -- as measured by retweets -- came from Roche's      official Genentech Twitter account that tweeted,      \"Nice antibody. Wanna conjugate?\"    <\/p>\n<p>      Educational? The meme is clearly      entertaining -- well at least most of them, some got a little      raunchy -- and it highlights that investors and companies can      have a little fun. Investing may be serious, but it doesn't      have to be stuffy.    <\/p>\n<p>      But the list of       pickup lines also serves as a nice glossary of terms that      every biotech investor should know. Genentech's tweet, for      example, refers to the process of adding drugs to antibodies      so the drug can be targeted to specific cells.      Seattle Genetics (NASDAQ: SGEN)      and ImmunoGen (NASDAQ:      IMGN)      have both developed technologies to produce antibody-drug      candidates; Roche's T-DM1 was developed using ImmunoGen's      technology.    <\/p>\n<p>      Here are a few more that contain terms you should know:    <\/p>\n<p>      There are plenty more, have a       look and if you find any that you just don't get, it      might be time for a little education to make you a better      biotech investor. Just don't try using them at the bar.    <\/p>\n<p>      Your date withdestinyIf you're an      investor looking for big long-term winners, Motley Fool      co-founder David Gardner's picks have frequently trounced the      market. How? Because he's always onthe      lookout for revolutionary stocksand recommends them      before Wall Street catches on to their disruptive potential.      If you're interested in how David discovers his      winners,click      here to get instant accessto a personal tour behind      David'sSupernovaservice.    <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Link: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/rss.feedsportal.com\/c\/34518\/f\/631681\/s\/276f923e\/l\/0L0Sfool0N0Cinvesting0Cgeneral0C20A130C0A10C110Cthe0Emost0Einteresting0Ething0Eat0Ejpmorgans0Ehealth0Ecar0Baspx0Dsource0Fehesitrf0A0A0A0A0A0A1\/story01.htm\" title=\"The Most Interesting Thing at JPMorgan&#39;s Health Care Conference\">The Most Interesting Thing at JPMorgan&#39;s Health Care Conference<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> By Brian Orelli | More Articles January 11, 2013 | JPMorgan's health care conference is a treasure-trove of information about health care companies. From basic information to fourth quarter sales, even a few deals are signed, sealed, and announced at JPMorgan <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/health-care\/the-most-interesting-thing-at-jpmorgans-health-care-conference.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[6],"tags":[],"class_list":["post-69815","post","type-post","status-publish","format-standard","hentry","category-health-care"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/69815"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=69815"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/69815\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=69815"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=69815"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=69815"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}